Stock Events

Stock Events

XOMA Royalty 

€32.8
0
+€1.6+5.13% Tuesday 07:15

Statistics

Day High
32.8
Day Low
32.8
52W High
33.4
52W Low
17.4
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30AprExpected
Next
0.13
0.47
0.8
1.13
Expected EPS
0.13349227500000002
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow X0M1.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap79.17B
Regeneron Pharmaceuticals competes in the biotechnology industry focusing on developing and commercializing medicines for serious medical conditions, similar to XOMA's focus on antibody-based therapeutics.
AMGEN
AMGN
Mkt Cap189.22B
Amgen is a biopharmaceutical company that discovers, develops, manufactures, and delivers innovative human therapeutics, competing directly with XOMA in the biotech sector.
Biogen
BIIB
Mkt Cap25.38B
Biogen competes with XOMA in the biotechnology field, focusing on developing therapies for neurological and neurodegenerative diseases.
Gilead Sciences
GILD
Mkt Cap172.51B
Gilead Sciences is a biopharmaceutical company that researches, develops, and commercializes drugs in areas similar to XOMA, making them direct competitors.
Vertex Pharmaceuticals
VRTX
Mkt Cap110.97B
Vertex Pharmaceuticals is involved in creating new possibilities in medicine to cure diseases and improve people's lives, competing with XOMA in the biotech innovation space.
Alnylam Pharmaceuticals
ALNY
Mkt Cap42.72B
Alnylam Pharmaceuticals is a leader in RNAi therapeutics, competing with XOMA in the development of novel therapeutics.
Incyte
INCY
Mkt Cap19.12B
Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics, making it a competitor in the biopharmaceutical space alongside XOMA.
Nektar Therapeutics
NKTR
Mkt Cap2.22B
Nektar Therapeutics is involved in developing new treatment options in various therapeutic areas, competing with XOMA in the innovation of biologic drugs.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.49B
BioMarin Pharmaceutical focuses on developing and commercializing innovative biopharmaceuticals for rare diseases, competing with XOMA in targeting niche markets with specialized treatments.

About

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Show more...
CEO
Mr. Owen P. Hughes Jr.
Employees
14
Country
Bermuda
ISIN
US98419J2069

Listings

F
DE
X0M1.F
MU
DE
X0M1.MU
F
DE
X0M.F
BOATS
BOATS
XOMAO.BOATS

0 Comments

Share your thoughts

FAQ

What is XOMA Royalty stock price today?▼
The current price of X0M1.MU is €32.8 EUR — it has increased by +5.13% in the past 24 hours. Watch XOMA Royalty stock price performance more closely on the chart.
What is XOMA Royalty stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange XOMA Royalty stocks are traded under the ticker X0M1.MU.
Is XOMA Royalty stock price growing?▼
X0M1.MU stock has risen by +7.89% compared to the previous week, the month change is a +41.38% rise, over the last year XOMA Royalty has showed a +79.23% increase.
When is the next XOMA Royalty earnings date?▼
XOMA Royalty is going to release the next earnings report on April 30, 2026.
How many employees does XOMA Royalty have?▼
As of April 15, 2026, the company has 14 employees.
In which sector is XOMA Royalty located?▼
XOMA Royalty operates in the Health & Wellness sector.
When did XOMA Royalty complete a stock split?▼
XOMA Royalty has not had any recent stock splits.
Where is XOMA Royalty headquartered?▼
XOMA Royalty is headquartered in Emeryville, Bermuda.